ImageneBio

IMANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$64.590 M

$5.69 +1.07%

Close of 7 Aug 2026

Revenue

$800.0K

#3520 by revenue

Earnings

-$45.3M

Loss-making

Shares outstanding

11,351,456

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#119Champions OncologyCSBR$72.1M
#120Eloxx PharmaceuticalsELOX$70.9M
#121ImageneBioIMA$64.6M
#122Genenta Science S.p.A.GNTA$62.7M
#123ScilexSCLX$59.0M

Where these numbers come from

Share counts and financials for ImageneBio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.